April 18 Medicaid won't expand in Kansas anytime soon. HB 2552, which requires an act of the Legislature to expand Medicaid through the Affordable Care Act, has been signed by Gov. "It doesn't take a position on whether or not Medicaid expansion under the Affordable Care Act should take place in Kansas.
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Mercy and Humana Inc., one of the nation's leading health and well-being companies, have partnered to develop an Accountable Care relationship designed to improve the health outcomes for Humana Medicare Advantage members in Southwest Missouri. Humana's Accountable Care Contin
By a News Reporter-Staff News Editor at Investment Weekly News The Tufts Medical Center Board of Trustees announced that it has voted unanimously to appoint Michael Wagner, MD, FACP as President and CEO of Tufts Medical Center and Floating Hospital for Children on a permanent basis. Wagner's performance in the interim CEO role over the past six m
A healthy workforce is a healthy economy. It's a business investment, "said the CEO of a large insurance company as we toured his Nebraska facility. It is estimated that job absenteeism due to poor health costs America $153 billion a year.
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Rite Aid Corporation announced it has acquired Boston- based Health Dialog Services Corporation, a leading provider of health coaching, shared decision making and healthcare analytics from Bupa, a London- based international healthcare services group. "We are extremely pleas
In response Stephen Whitehead, Chief Executive of the Association of the British Pharmaceutical Industry, has said:. 'The MHRA are one of the best and most respected regulators in Europe and over the past year, they have played a key role in some very important developments that will positively impact both our industry and public health. 'The MHRA
Two recent studies published in The American Journal of Managed Care have found that state Medicaid policies restricting access to newer antipsychotic medications can drive up healthcare costs down the line, in part because psychiatric patients are more likely to go off medication. The studies found that in states where doctors face hurdles in...
BioAlliance Pharma SA, a company specialized in the development of drugs within orphan oncology diseases, and Topotarget A/S, a Scandinavian-based biopharmaceutical company, have announced their intention to merge to create a leading orphan oncology company with a highly complementary pipelines of late-stage products addressing significant unmet...
Waseela-e-Sehat comprises of Group Life Insurance and Health Insurance coverage for the BISP beneficiary families. The pilot phase of Health Insurance was launched in Faisalabad district in April 2012 and approximately fifty nine thousand beneficiary families were enrolled in the programme while eight hospitals in the district were empanelled
Boston Scientific Corp. has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. These newly approved devices continue the Boston Scientific history of projected longevity and a six-year CRT-D warranty. Extending the Boston Scientific portfolio of defibrillators, the ICDs in t
April 18 Medicaid won't expand in Kansas anytime soon. But it was amended on the Senate floor to include a provision that requires an act of the Legislature to expand Medicaid, which is possible through the Affordable Care Act. "It doesn't take a position on whether or not Medicaid expansion under the Affordable Care Act should take place in Kan
By a News Reporter-Staff News Editor at Health& Medicine Week "Our new software collects radiation dose details from our CR and DR systems and sends this data to PACS systems that support the IHE dose monitoring profile," said Helen Titus, Carestream's Marketing Director of X-ray Solutions. "We are one of the first companies to provide radiation
Certara, a technology-enabled drug development and drug safety consultancy, announced that it has acquired specialty contract research organization Synchrogenix Information Strategies Inc.. Donald A. Deieso, Chairman of Certara, said, "Pharmaceutical companies are looking for greater value and increased synergies from their outsourcing partners.
By a News Reporter-Staff News Editor at Insurance Weekly News Inovalon, Inc., a leading technology company providing advanced analytics and data-driven solutions to the healthcare industry, announced medication quality performance measurement research to be presented at the Academy of Managed Care Pharmacy 26 Annual Meeting& Expo April 1-4 in Tam
Sandlot Solutions, a community health interoperability and analytics provider, announced the beginning of a five-year contract with Dialysis Clinic, Inc., a nonprofit corporation providing care for patients with kidney disease. A certified Medicare dialysis provider operating in 28 states, DCI will implement two Sandlot modules, Sandlot Connect, fo
Easton Pharmaceuticals announced that BMV Medica, S.A. de C.V., a Mexican regulatory company and distributor of pharmaceutical products have signed an exclusive agreement to distribute Easton's "Viorra" product in Mexico. Carla Pepe, CEO of Easton Pharmaceuticals, stated, "BMV Medica, as previously announced, is the company's current regulatory con
Release date- 17042014- The U.S. Food and Drug Administration today approved Ragwitek, the first allergen extract administered under the tongue to treat short ragweed pollen induced allergic rhinitis, with or without conjunctivitis, in adults 18 years through 65 years of age. 'The approval of Ragwitek offers millions of adults living with ragweed p
By a News Reporter-Staff News Editor at Insurance Weekly News FDB, the leading provider of clinical drug knowledge that helps improve medication-related decisions and patient outcomes, announced that it will present a poster at the Academy of Managed Care Pharmacy 26th Annual Meeting, April 1- 4, 2014, in Tampa, Florida and the International Soci
By a News Reporter-Staff News Editor at Health& Medicine Week Investigators publish new report on Magnetic Resonance. According to news reporting originating from Hyogo, Japan, by NewsRx editors, the research stated, "Since the clinical introduction of magnetic resonance imaging, the chest has been one of its most challenging applications, and si
Peter G. Traber, President, Chief Executive Officer, and Chief Medical Officer of Galectin Therapeutics Inc. "These positive results have propelled the enrollment of the second cohort with strong participation across our clinical trial sites. In 2013, Galectin Therapeutics received Fast Track designation from the FDA for this clinical development..
Release date- 17042014- GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration has approved a Supplemental Biologic License Application for the use of Arzerra, a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic...
April 17 AUGUSTA, Maine The debate over Medicaid expansion has dominated the 126th Legislature, and it will continue to do so as the session winds down and lawmakers prepare to head back to their districts. Rather than simply expanding Medicaid permanently to 70,000 low-income Mainers as originally envisioned by the 2010 federal Affordable Care
Total spending on U.S. medicines increased 1.0 percent on a real per capita basis in 2013, while the use of healthcare services overall rose for the first time in three years, according to a new report issued today by the IMS Institute for Healthcare Informatics. The study- Medicine Use and Shifting Costs of Healthcare: A Review of the Use of Medic
Waseela-e-Sehet comprises of Group Life Insurance and Health Insurance coverage for the BISP beneficiary families. The pilot phase of Health Insurance was launched in Faisalabad district in April 2012 and approximately fifty nine thousand beneficiary families were enrolled in the programme while eight hospitals in the district were empanelled
Lannett Company, Inc. said that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Diazepam Oral Solution, 5 mg/ mL, a Schedule C-IV controlled drug. "We believe our ANDA for Diazepam Oral Solution, 5 mg/mL was the first bioequivalent Diazepam Oral Solution product approved by the FDA,"